InvestorsHub Logo
Followers 319
Posts 15832
Boards Moderated 0
Alias Born 01/02/2010

Re: None

Tuesday, 06/27/2017 11:20:13 AM

Tuesday, June 27, 2017 11:20:13 AM

Post# of 8422
"Synthetic Biologics: USPTO has issued a Notice of Allowance for its patent application covering the use of the active agent of lead product product candidate SYN-010, its modified-release formulation of lovastatin lactone, for the treatment of constipation.

The company is preparing to launch a Phase 2b/3 pivotal trial to further assess the safety and efficacy of SYN-010.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News